Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Considering that the incidence of specific RAS mutations varies from cancer type to cancer type, it is clear the need for developing effective treatments against other RAS-mutations different to ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

For instance, growth-promoting genes, such as the gene for the signaling protein Ras, are among those most commonly mutated in cancer cells, becoming super-active and producing cells that are too ...

Over the past two decades, several methods have been developed to allow comparative studies of gene expression between normal and cancer cells. Starting with simple approaches that used gel ...